Short- and Medium-term Safety/Effectiveness Analysis of Low Energy Holmium Laser Enucleation of the Prostate (HoLEP)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0005154

Enrollment

Registered

2020-06-23

Start date

2020-09-14

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : All patients should have this surgery on the lithotomy position under either spinal or general anesthesia and a single surgeon performs all the operations. After anesthesia, the ureth

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: ? A man over 50 years old ? Who is decided holmium laser surgery for benign prostatic hyperplasia ? A patient who has a full understanding and agreement with the study

Exclusion criteria

Exclusion criteria: ? Patients with neurological diseases that can adversely affect urinary function (Parkinson's disease, dementia, etc.) ? Patients suffering from acute urinary retention within the last month ? Patients with urinary infection symptom ? In case there are factors that can have a significant effect on the results of treatment based on the judgement of the other researchers

Design outcomes

Primary

Measure	Time frame
Efficacy, International Prostate Symptom Score(IPSS), Uroflowmetry(UFM), Postvoid Residual Volume(PRV)	—

Secondary

Measure	Time frame
Safety, Complications, Adverse events	—

Countries

Korea, Republic of

Contacts

Public ContactJunGyo Suh

Seoul National University Hospital

crazyslime@gmail.com+82-2-2072-2406

Outcome results